Coagulation and fibrinolysis in thyroid disease

Area of Science:

• Endocrinology
• Hematology
• Thrombosis Research

Background:

• Thyroid hormones influence various physiological processes, including hemostasis.
• Alterations in thyroid status (hyperthyroidism and hypothyroidism) may affect coagulation and fibrinolysis.
• Understanding these effects is crucial for managing associated risks.

Purpose of the Study:

• To compare coagulation and fibrinolytic system components in hyperthyroid, hypothyroid, and euthyroid individuals.
• To identify specific hemostatic markers affected by thyroid dysfunction.

Main Methods:

• Comparative analysis of coagulation and fibrinolytic parameters.
• Inclusion of 20 hyperthyroid, 9 hypothyroid, and 20 euthyroid subjects.
• Measurement of fibrinolytic activity, plasminogen, alpha1-antitrypsin, C1 inactivator, alpha2-macroglobulin, partial thromboplastin time, factor XII, and antithrombin III.

Main Results:

• Hyperthyroid patients showed reduced fibrinolytic activity and plasminogen, with increased alpha1-antitrypsin and C1 inactivator.
• Hypothyroid patients exhibited increased fibrinolytic activity and alpha2-macroglobulin, prolonged partial thromboplastin time, and reduced factor XII and antithrombin III levels.

Conclusions:

• Thyroid dysfunction significantly alters components of the coagulation and fibrinolytic systems.
• Hyperthyroidism and hypothyroidism are associated with distinct hemostatic profiles.
• These findings highlight the complex interplay between thyroid hormones and blood clot regulation.